M-14008 Alpha-Fetoprotein (AFP) Quantitative Test Kit

Clinical Significance: Alpha-fetoprotein (AFP) is an embryonic protein primarily produced by the liver and yolk sac of the fetus. It is a specific protein present in the blood during the embryonic period, synthesized only in the fetal liver cells, with the highest levels found between 16 to 20 weeks of gestation. After birth, AFP levels drop rapidly and are undetectable or very low in the blood. However, in cases of primary liver cancer, testicular tumors in children, or ovarian teratomas in women, AFP production resumes and it reappears in the blood. Thus, measuring AFP levels in the blood is crucial for detecting and diagnosing these conditions. In healthy adults, serum AFP levels are usually below 20 micrograms per liter.
Product Specifications: 20 tests per box
Product Shelf Life: Sealed in an aluminum foil bag, the product is valid for 18 months. Once opened, the aluminum foil bag should be used within 1 hour.
Product Storage: Store the test cards at 2°C to 30°C.
 
Usage Scenarios:
Hospitals and Oncology Departments: For diagnosing and monitoring primary liver cancer, testicular tumors in children, and ovarian teratomas in women.
Pediatric Clinics: For early detection of testicular tumors in children.
Diagnostic Laboratories: For routine screening of alpha-fetoprotein (AFP) levels in patients at risk for certain cancers.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are widely used for comprehensive cancer management and early detection.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding diagnostic capabilities for early detection and management of cancers.
Global Health Programs: International health initiatives focused on enhancing cancer detection and management in low-resource settings.